Physician profile
David Epstein
NPI 1598262511
$7,902.17
in general payments reported to CMS, 2019-2025
16 companies · $650 in 2025
The $650 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $1,017 · 2023: $954 · 2024: $5,130 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $4,063 · Food and Beverage: $2,272 · Education: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $4,063.30 |
| Food and Beverage | $2,271.64 |
| Education | $399.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,167.80 | 2022-2025 | Onyx Frontier, Symplicity G3, Telescope |
| Boston Scientific Corporation | $1,116.26 | 2022-2025 | Wolverine Coronary Cutting Balloon, Synergy |
| Astrazeneca Pharmaceuticals LP | $736.99 | 2021-2024 | Farxiga, Brilinta |
| Abiomed | $454.23 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $313.19 | 2022-2025 | Camzyos, Eliquis |
| Amgen INC. | $233.51 | 2022-2025 | Repatha |
| Philips North America LLC | $228.56 | 2024-2025 | Igt Devices Undivided, Coronary Other, (P88) Igt Devices Fm |
| Astellas Pharma US INC | $186.99 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $165.68 | 2021-2022 | |
| Pfizer INC. | $64.66 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $60.15 | 2025 | Amvuttra |
| Biotronik INC. | $53.59 | 2022-2024 | Pamira |
| Sanofi-Aventis U.S. LLC | $50.00 | 2021-2022 | |
| Shockwave Medical, INC | $33.49 | 2025 | |
| Janssen Pharmaceuticals, INC | $22.44 | 2024 | Xarelto |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $14.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.